Back
Aldeyra Therapeutics 10K Form
Sell
34
ALDX
Aldeyra Therapeutics
Last Price:
$2.36
Seasonality Move:
25.51%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive ALDX News And Ratings
See the #1 stock for the next 7 days that we like better than ALDX
ALDX Financial Statistics
Sales & Book Value
Annual Sales: | $0 |
---|---|
Cash Flow: | $-12.5M |
Price / Cash Flow: | 0 |
Annual Sales: | $1.06 |
Price / Book: | 2.28 |
Profitability
EPS (TTM): | -0.97000 |
---|---|
Net Income (TTM): | $-57.7M |
Gross Margin: | $0 |
Return on Equity: | 0% |
Return on Assets: | 0% |
Aldeyra Therapeutics Earnings Forecast
Key Aldeyra Therapeutics Financial Ratios
-
Per Share Earnings over the last 14 years have been positive in 8 years.
Aldeyra Therapeutics Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Biotechnology |
Sector: | Health Care |
Current Symbol: | ALDX |
CUSIP: | 01438T |
Website: | aldeyra.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 0 |
Quick Ratio: | 0 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 6.13 |
ALDX Technical Analysis vs Fundamental Analysis
Sell
34
Aldeyra Therapeutics (ALDX)
is a Sell
Is Aldeyra Therapeutics a Buy or a Sell?
-
Aldeyra Therapeutics stock is rated a SellThe current Aldeyra Therapeutics [ALDX] share price is $2.42. The Score for ALDX is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.